Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial
Titel:
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial
Auteur:
Becker, Jürgen C Ugurel, Selma Leiter, Ulrike Meier, Friedegund Gutzmer, Ralf Haferkamp, Sebastian Zimmer, Lisa Livingstone, Elisabeth Eigentler, Thomas K Hauschild, Axel Kiecker, Felix Hassel, Jessica C Mohr, Peter Fluck, Michael Thomas, Ioannis Garzarolli, Marlene Grimmelmann, Imke Drexler, Konstantin Spillner, Alexandra N Eckhardt, Sebastian Schadendorf, Dirk